Skip to main content
. 2017 Mar 10;8(16):27216–27239. doi: 10.18632/oncotarget.16111

Table 2. CAP1 expression in cancers.

Cancer cancer subtype p −value fold change rank (%) sample reference
Bladder Infiltrating Bladder Urothelial Carcinoma 7.84E5 2.046 10 27 [25]
Breast Invasive Breast Carcinoma Stroma 9.62E–30 −15.461 2 59 [26]
Head and Neck Tongue Squamous Carcinoma 1.68E–12 3.333 1 57 [27]
Tonsillar Carcinoma 4.23E–5 2.1036 1 10 [28]
Tongue Carcinoma 4.3E–7 2.439 2 19 [28]
Oropharyngeal Carcinoma 7.91E–5 2.1 3 10 [28]
Tongue Squamous Carcinoma 1.37E–11 3.095 2 57 [29]
Leukemia Chronic lymphocytic leukemia 9.13E–6 2.212 5 111 [30]
Acute myeloid leukemia 3.79E–7 −5.989 1 31 [31]
T−cell acute lymphoblastic 8.00E–9 −3.731 2 17 [32]
Acute myeloid leukemia 2.59E–7 −2.198 5 144 [32]
T−cell acute lymphoblastic 1.25E–7 −3.135 9 93 [32]
Lung Squamous cell lung Carcinoma 4.89E–13 3.2211 1 26 [29]
Lymphoma Anaplastic larger cell lymphoma 9.81E–5 2.140 1 27 [33]
Angioimmunoblastic T−cell lymphoma 9.82E–10 2.874 1 26 [33]
Unspecified peripheral T−cell lymphoma 2.79E–13 2.391 3 48 [33]
Melanoma Cutaneous Melanoma 2.31E–5 3.629 8 52 [34]
Pancreatic Pancreatic carcinoma 1.42E–5 4.732 1 17 [35]
Pancreatic adenocarcinoma 5.83E–5 2.958 4 15 [36]
Pancreatic carcinoma 6.86E–5 2.308 8 52 [37]
Pancreatic ductal adenocarcinoma 1.24E–9 2.520 5 78 [38]
Other Embryonal carcinoma 1.16E–7 2.689 5 20 [39]
Seminoma, NOS 5.64E–9 2.112 2 18 [39]
Teratoma, NOS 1.60E–8 2.067 3 20 [39]